TCM
ARKG icon

True Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

True Capital Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$306K Sell
10,168
-275
-3% -$8.52K 0.21% 93
2022
Q4 		$295K Buy
+10,443
New +$331K 0.24% 90

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

True Capital Management's ARKG Position: Q1 2023 in Review

True Capital Management reduced its ARK Genomic Revolution ETF (ARKG) stake by 2.6% in Q1 2023, selling an estimated $8.52K and leaving 10,168 shares worth $306K. The position accounts for 0.21% of the portfolio, ranked #93.

True Capital Management first reported a position in ARKG in Q4 2022 and has held it in 2 quarters since. 295 funds tracked by Wall St. Rank hold ARKG as of Q1 2023.

  • True Capital Management held 10,168 shares of ARK Genomic Revolution ETF worth $306K as of Q1 2023.
  • True Capital Management sold 275 ARK Genomic Revolution ETF shares in Q1 2023, an estimated $8.52K.
  • ARK Genomic Revolution ETF made up 0.21% of True Capital Management's portfolio in Q1 2023, its #93 holding.
  • True Capital Management first reported a position in ARK Genomic Revolution ETF in Q4 2022 and has held it in 2 quarters since.
  • 295 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2023.

Based on True Capital Management's 13F filing for Q1 2023, filed 2 May 2023.